Literature DB >> 2199394

Efficacy of orchiectomy versus high dose polyoestradiol phosphate (160 mg) in relieving infravesical obstruction in patients with prostatic cancer.

J Aro1, R Haapiainen, S Rannikko, O Alfthan.   

Abstract

Post voiding residual urine volume (78 patients) and maximum urinary flow rate (59 patients) were measured in prostatic cancer patients treated by orchiectomy or oestrogen (polyoestradiol phosphate 160 mg i.m. monthly) to compare the effects of these endocrine treatments on bladder outlet obstruction caused by prostatic carcinoma. The relieving effect of orchiectomy seemed to be more apparent than that of high dose oestrogen during the first six months of therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199394     DOI: 10.1007/bf02550436

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Ultrasonic method of measuring residual urine.

Authors:  O Alfthan; T Mattsson
Journal:  Ann Chir Gynaecol Fenn       Date:  1969

2.  Editorial: The choice of therapy for prostatic carcinoma.

Authors:  V F Marshall
Journal:  J Urol       Date:  1975-03       Impact factor: 7.450

3.  Ureteral obstruction from prostatic carcinoma: response to endocrine and radiation therapy.

Authors:  S Michigan; W J Catalona
Journal:  J Urol       Date:  1977-11       Impact factor: 7.450

4.  Transrectal ultrasonography in the followup of prostatic carcinoma patients.

Authors:  P J Carpentier; F H Schroeder; J H Blom
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

5.  Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment.

Authors:  E Varenhorst; G Alund
Journal:  Urology       Date:  1985-04       Impact factor: 2.649

6.  High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.

Authors:  J L Aro; R K Haapiainen; S A Rannikko; O S Alfthan
Journal:  Br J Urol       Date:  1989-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.